#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	15150	16S	1529	1529	100.0	16S.l15.c17.ctg.1	2115	711.5	1	SNP	n	C1184T	0	.	.	1184	1184	C	1448	1448	C	877	C	810	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	15150	16S	1529	1529	100.0	16S.l15.c17.ctg.1	2115	711.5	0	HET	.	.	.	C207T	.	207	207	C	471	471	C	836	C,T	629,158	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27026	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3752	718.5	0	.	n	.	0	T695C	SNP	695	695	T	1068	1068	C	884	C	836	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27026	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3752	718.5	0	.	n	.	0	A1638G	SNP	1638	1638	A	2011	2011	G	915	G	863	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27026	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3752	718.5	0	.	n	.	0	T1971C	SNP	1971	1971	T	2344	2344	C	874	C	805	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27026	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3752	718.5	1	SNP	n	A2045G	0	.	.	2045	2045	A	2418	2418	A	853	A	820	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27026	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3752	718.5	1	SNP	n	C2597T	0	.	.	2597	2597	C	2970	2970	C	861	C,T	813,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	2020	folP	855	855	100.0	folP.l6.c30.ctg.1	1564	128.9	1	SNP	p	R229S	1	.	.	685	687	AGC	1047	1049	AGC	204;207;213	A;G;C	193;197;200	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5448	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3410	159.3	1	SNP	p	S91F	1	.	.	271	273	TTC	550	552	TTC	170;171;171	T;T;C	162;163;160	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5448	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3410	159.3	1	SNP	p	D95G	1	.	.	283	285	GGC	562	564	GGC	167;163;163	G;G;C	161;158;158	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5448	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3410	159.3	1	SNP	p	G95N	0	.	.	283	285	GGC	562	564	GGC	167;163;163	G;G;C	161;158;158	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	1592	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1422	111.5	1	SNP	p	G45D	0	.	.	133	135	GGC	533	535	GGC	188;185;183	G;G;C	175;172;174	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	844	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c30.ctg.1	957	86.9	0	.	n	.	0	A197.	DEL	197	197	A	532	532	A	194	A	189	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5838	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3028	192.4	1	SNP	p	D86N	0	.	.	256	258	GAC	627	629	GAC	204;204;204	G;A;C	197;193;195	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5838	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3028	192.4	1	SNP	p	R87W	0	.	.	259	261	CGT	630	632	CGT	205;206;205	C;G;T	200;194;191	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5838	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3028	192.4	1	SNP	p	S87R	1	.	.	259	261	CGT	630	632	CGT	205;206;205	C;G;T	200;194;191	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5838	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3028	192.4	1	SNP	p	R87I	0	.	.	259	261	CGT	630	632	CGT	205;206;205	C;G;T	200;194;191	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5838	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3028	192.4	1	SNP	p	S88P	0	.	.	262	264	TCC	633	635	TCC	204;204;208	T,A;C;C	192,1;194;194	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4212	parE	1986	1986	100.0	parE.l6.c4.ctg.1	2674	157.0	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1607	1609	GGC	215;215;213	G;G;C,T	203;201;199,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3984	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2358	167.9	1	SNP	p	A311V	0	.	.	931	933	GCC	1177	1179	GCC	226;222;226	G;C;C,A	216;215;215,1	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3984	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2358	167.9	1	SNP	p	I312M	1	.	.	934	936	ATG	1180	1182	ATG	225;227;225	A;T;G,T	216;217;214,1	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3984	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2358	167.9	1	SNP	p	T316P	0	.	.	946	948	ACC	1192	1194	ACC	211;211;210	A;C;C	201;202;201	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3984	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2358	167.9	1	SNP	p	V316T	1	.	.	946	948	ACC	1192	1194	ACC	211;211;210	A;C;C	201;202;201	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3984	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2358	167.9	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1693	1695	ACC	227;226;226	A;C;C	207;205;206	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3984	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2358	167.9	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1747	1749	GCG	222;221;221	G;C;G	207;208;207	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3984	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2358	167.9	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1747	1749	GCG	222;221;221	G;C;G	207;208;207	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3984	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2358	167.9	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1870	1872	GGT	174;176;178	G;G;T	158;160;161	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3984	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2358	167.9	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1879	1881	AGC	174;172;171	A;G;C	157;156;154	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3984	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2358	167.9	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1897	1899	CCG	163;164;165	C,G;C,G;G	130,7;128,2;132	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5860	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3203	182.5	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1733	1735	CCG	227;227;229	C;C;G	207;214;210	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2434	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1759	137.4	0	.	p	.	0	M83fs	FSHIFT	247	247	A	539	539	C	171	C	157	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2762	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	1800	153.0	1	SNP	p	G120K	1	.	.	358	360	AAG	753	755	AAG	228;227;228	A;A;G	217;216;216	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2762	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	1800	153.0	1	SNP	p	A121N	1	.	.	361	363	AAC	756	758	AAC	228;227;224	A;A;C	217;217;215	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2762	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	1800	153.0	1	SNP	p	N121D	0	.	.	361	363	AAC	756	758	AAC	228;227;224	A;A;C	217;217;215	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10234	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4862	209.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1142	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1028	110.1	1	SNP	p	V57M	1	.	.	169	171	ATG	465	467	ATG	246;247;246	A;T,C;G	235;235,1;235	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
